Yaman Onder, Akand Murat, Gursoy Alptekin, Erdogan Murat Faik, Anafarta Kadri
Department of Urology, University of Ankara, School of Medicine, Ankara, Turkey.
J Sex Med. 2006 Mar;3(2):344-8. doi: 10.1111/j.1743-6109.2006.00221.x.
Erectile dysfunction (ED) is a common complication of diabetes mellitus (DM). However, efficacy and/or long-term satisfaction with most of those ED treatment options have been suboptimal.
In this study we try to evaluate the effect of aggressive treatment and DM regulation on the erectile function in men with DM-induced ED (DMED).
Eight type 1 and 17 type 2 diabetic subjects were included into the study. All patients had a measurement of fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1(c)) levels, and completed three sessions of consecutive nights using the RigiScan Plus monitoring device before and after blood sugar control. Also International Index of Erectile Function (IIEF) questionnaire scores were obtained before and after blood sugar control.
Significant improvement was noted in FPG and HbA1(c) levels throughout the treatment period (P < 0.001). However, no statistically significant difference was observed in both IIEF scores and nocturnal penile tumescence and rigidity (nptr) parameters after the dm regulation (p > 0.05).
We suggest that there are probably other factors than aggressive treatment and DM regulation for treating DMED, and probably we must consider preventive strategies with pharmacological agents to prevent progressive decrease in erectile function in diabetic patients.
勃起功能障碍(ED)是糖尿病(DM)的常见并发症。然而,大多数ED治疗方案的疗效和/或长期满意度一直不尽人意。
在本研究中,我们试图评估积极治疗和糖尿病控制对糖尿病性勃起功能障碍(DMED)男性勃起功能的影响。
8名1型糖尿病患者和17名2型糖尿病患者被纳入研究。所有患者均测量了空腹血糖(FPG)和糖化血红蛋白(HbA1(c))水平,并在血糖控制前后使用RigiScan Plus监测设备连续三个晚上进行监测。此外,在血糖控制前后获取国际勃起功能指数(IIEF)问卷评分。
在整个治疗期间,FPG和HbA1(c)水平有显著改善(P < 0.001)。然而,糖尿病控制后,IIEF评分以及夜间阴茎肿胀和硬度(nptr)参数均未观察到统计学上的显著差异(P > 0.05)。
我们认为,治疗DMED可能除了积极治疗和糖尿病控制外还有其他因素,并且可能必须考虑使用药物进行预防策略,以防止糖尿病患者勃起功能逐渐下降。